Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-β receptor type I and type II in human pituitary adenomas

Clinical Neuropathology

Volumn 17, Issue 1, 1998, Pages 19-26

  Fujiwara, K ^a   Ikeda, H ^a   Yoshimoto, T ^a  

^a TOHOKU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Molecular analysis; mRNA; PCR; Pituitary adenoma; TGF receptor

Indexed keywords

RECEPTOR SUBTYPE; TRANSFORMING GROWTH FACTOR BETA RECEPTOR;

ADULT; AGED; ARTICLE; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; TRANSCRIPTION REGULATION; TUMOR GROWTH;

ADENOMA; ADULT; AGED; CHILD, PRESCHOOL; CHROMOSOME ABERRATIONS; CHROMOSOME DISORDERS; DNA, COMPLEMENTARY; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC CODE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUTATION; NEOPLASM PROTEINS; PITUITARY NEOPLASMS; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE-STRANDED CONFORMATIONAL; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; RNA, MESSENGER; TRANSCRIPTION, GENETIC;

EID: 0031915874     PISSN: 07225091     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (32)

1. Alexander JM, Bikkal HA, Zervas NT, Laws ER, Klibanski A 1996 Tumor-specific expression, alternate splicing of messenger ribonucleic acid encoding activin/transforming growth factor-β receptors in human pituitary adenomas. J Clin Endocrinol Metab 81: 783-790
2. Brand T, Schneider MD 1995 Inactive type II and type I receptors for TGFβ are dominant inhibitors of TGFβ-dependent transcription. J Biol Chem 270: 8274-8284
3. Braun L, Mead JE, Panzica M, Mikumo R, Bell GI, Fausto N 1988 Transforming growth factor β mRNA increases during liver regeneration: a possible paracrine mechanism of growth regulation. Proc Natl Acad Sci USA 85: 1539-1543
4. Carr BI, Hayashi I, Branum EL, Moses HL 1986 Inhibition of DNA synthesis in rat hepatocytes by platelet-derived type transforming growth factor. Cancer Res 46: 2330-2334
5. Chelly J, Kaplan JC, Maire P, Gautron S, Kahn A 1988 Transcription of the dystrophin gene in human muscle and non-muscle tissues. Nature 333: 858-861
6. Chen RH, Moses HL, Maruoka EM, Derynch R, Kawabata M 1995 Phosphorylation-dependent interaction of the cytoplasmic domains of the type I type II transforming growth factor-β receptors. J Biol Chem 270: 12235-12241
7. Franzen P, Dijke PT, Ichijo H, Yamashita H, Schulz P, Heildin CH, Miyazono K 1993 Cloning of a TGFβ type I receptor that forms a heterometric complex with the TGFβ type II receptor. Cell 45: 681-692
8. Fujiwara K, Ikeda H, Yoshimoto T 1995a Immunohistochemical demonstration of TGF-Beta-receptor type II in human pituitary adenomas. Acta Histochemica 97: 445-454
9. Fujiwara K, Ikeda H, Yoshimoto T 1995b Immunohistochemical demonstration of transforming growth factor-beta-1 in human pituitary adenomas. Acta Histochem Cytochem 28: 333-339
10. Garrigue-Antar L, Munoz-Antonia T, Antonia SJ, Gesmonde J, Vellucci VF, Reiss M 1995 Missense mutation of the transforming growth factor β type II receptor in human head neck squamous carcinoma cells. Cancer Res 55: 3982-3987
11. Hsu SM, Raine L, Fanger H 1981 Use of avidin-biotin-peroxidase complex (ABC) in immuno-peroxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 29: 577-580
12. Ikeda H, Yoshimoto T 1992 The relationship between c-myc protein expression, the bromodeoxyuridine labeling index, and the biological behavior of pituitary adenomas. Acta Neuropathol 83: 361-364
13. Ikeda H, Beauchamp RL, Yoshimoto T, Yandel DW 1995 Detection of heterozygous mutation in the retinoblastoma gene in a human pituitary adenoma using PCR-SSCP analysis and direct sequencing. Endocrinol Pathol 6: 189-196
14. 1 in human prostate cancer cells. Cancer Res 56: 44-48
15. Knabbe C, Lippman ME, Wakefield LM, Flanders KC, Kasid A, Derynck R, Dickson RB 1987 Evidence that transforming growth factor-β is a hormonally regulated negative growth factor in human breast cancer cells. Cell 48: 417-28
16. Laiho M, DeCaprio JA, Ludlow JW, Livingston DM, Massagué J 1990 Growth inhibition by TGF-β linked to suppression of retinoblastoma protein phosphorylation. Cell 62: 175-185
17. Markowitz S, Wang J, Myeroff L, Parsons R, Sun L, Lutterbaugh J, Fan RS, Zborowska E, Kinzler KW, Vogelstein B, Brattain M, Willson JKV 1995 Inactivation of the type II TGF-b receptor in colon cancer cells with microsatellite instability. Science 268: 1336-8
18. Mosui T, Wakefield LM, Lechner JF, LaVeck MA, Sporn MB, Harris CC 1986 Type β transforming growth factor is the primary differentiation-inducing serum factor for normal human bronchial epithelial cells. Proc Natl Acad Sci USA 83: 2438-2442
19. McMahon JB, Richards WL, del Campo AA, Song MKH, Thorgeirsson SS 1986 Differential effects of transforming growth factor-β on proliferation of normal and malignant rat liver epithelial cells in culture. Cancer Res 46: 4665-4671
20. 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ 3: 291-298
21. Mun̄oz-Antonia T, Li X, Reiss M, Jackson R, Antonia S 1996 A mutation in the transforming growth factor β type II receptor gene promoter associated with loss of gene expression. Cancer Res 56: 4831-4835
22. Myeroff L, Parsons R, Kim SJ, Hedrick L, Cho KR, Orth K, Mathis M, Kinzler KW, Lutterbaugh J, Park K, Bang YJ, Lee HY, Park JG, Lynch HT, Roberts AB, Vogelstein B, Markowitz SDA 1995 Transforming growth factor β receptor type II gene mutation common in colon and gastric but rare in endometrial cancers with microsatellite instability. Cancer Res 55: 5545-5547
23. Park K, Kim SJ, Bang YJ, Park JG, Kim NK, Roberts AB, Sporn MB 1994 Genetic changes in the transforming growth factor β (TGFβ) type II receptor gene in human gastric cancer cells: correlation with sensitivity to TGFβ. Proc Natl Acad Scid USA 91: 8772-8776
24. Parsons R, Myeroff LL, Liu B, Willson JKV, Markowitz SD, Kinzler KW, Vogelstein B 1995 Microsatellite instability and mutations of the transforming growth factor b type II receptor gene in colorectal cancer. Cancer Res 55: 5548-5550
25. 1 inhibition of c-myc transcription and growth in keratinocytes is abrogated by viral transforming proteins with pRB-binding domains. Cell 61: 777-785
26. Ristow HJ 1986 BSC-1 growth inhibitor/type β transforming growth factor is a strong inhibitor of thymocyte proliferation. Proc Natl Acad Sci USA 83: 5531-5533
27. Russell WK, Coffey RJ, Ouellette AJ, Moses HL 1988 Type β transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. Proc Natl Acad Sci USA 85: 5126-5130
28. Schneider E, Cowan KH, Barder H, Toomey S, Schwartz GN, Karp JE, Burke PJ, Kaufmann SH 1995 Increased expression of the multidrug resistance-associated protein gene in relapsed acute leukemia. Blood 85: 186-193
29. Silberstein GB, Daniel CW 1987 Reversible inhibition of mammary gland growth by transforming growth factor-β. Science 237: 291-293
30. Skinner MK, Keski-Oja J, Osteen KG, Moses HL 1987 Ovarian thecal cells produce transforming growth factor-β which can regulate granulosa cell growth. Endocrinology 121: 786-792
31. Wang J, Sun L, Myeroff L, Waang X, Gentry LE, Yang J, Liang J, Zborowska E, Markowitz S, Willson JKV, Brattain MG 1995 Demonstration that mutation of the type II transforming growth factor β receptor inactivates its tumor suppressor activity in replication error - positive colon carcinoma cells. J Biol Chem 270: 22044-22049
32. Wrana JL, Attisano L, Wieser R, Ventura F, Massagu J 1994 Mechanism of activation of the TGF-β receptor. Nature 370: 341-347